Enjoy complimentary customisation on priority with our Enterprise License!
The ALS treatment market size is estimated to grow by USD 663.7 million at a CAGR of 12.79% between 2023 and 2028. ALS, or amyotrophic lateral sclerosis, is a neurodegenerative disease. Market growth is driven by the rising incidence of ALS, unmet treatment needs, increased research funding for neurodegenerative disease therapeutics, aging population, and the development of novel drugs. Additionally The ALS treatment market addresses the urgent need for therapies to combat Lou Gehrig's disease and multiple sclerosis, motor neuron diseases characterized by nerve cell degeneration, genetic inheritance, and gene mutation, leading to glutamate accumulation and respiratory failure, affecting both men and women, with medications available through hospital pharmacies.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.